Background: Some of the genes belonging to cag pathogenicity island (cagPAI) in Helicobacter pylori were found to be associated with an increased severity of gastric mucosal inflammation that might lead to the development of gastroduodenal disease.
INTRODUCTION

M
any studies have confirmed the role of H. pylori in the development of chronic gastritis, gastric and duodenal ulcer and the ethiological role in the pathogenesis of gastric carcinoma and mucosaassociated lymphoid tissue (MALT) lymphoma.
H. pylori possess many virulence genes; one of them is cag pathogenicity island (cagPAI) (1) . CagPAI is since its discovery the most analysed base pairs region of H. pylori chromosome and contains around 30 genes divided into region I and II. CagPAI is defined as intact if all genes are present, parcially deleated as presence of several genes and negative (deleated) if there are no genes at all (2). Many studies report correlation between presence of intact cagPAI, partially deleated and deleated cagPAI and clinical outcome. Some authors correlate intact cagPAI with severe gastroduodenal diseases, with higher grade of chronic gastritis and premalignant lesions of gastric mucosa. (1, (3) (4) , while partially deleated and deleated cagPAI are associated with milder forms of gastroduodenal disease and lower grade of pathological alternations of gastric mucosa (5-6). On the contrary, some of the authors did not find correlation between cagPAI and gastroduodenal disease (7). CagPAI encodes multiple structural components of bacterial type IV secretion system (T4SS). T4SS translocates cagA protein directly to the cytosol of the gastric epitelium where it gets tyrosin phosphorylated by Src-family kinases and becomes able to alter the host cell functions leading to malignant transformation (2).
CagA gene is located in the region I of cagPAI and is considered to be the marker of this region. CagA positive isolates are associated with more severe clinical features in many studies. However, there are contradictory results in the references regarding these studies.
CagE is also located in the region I and is necessary to induce production of interleukin IL-8. Some authors consider cagE gene to be better marker of cagPAI region compared to cagA and more useful in monitoring the progress of H. pylori induced gastric disease. CagT gene is a marker of cagII region and some studies connect it with more severe clinical disease (8). LEC (left terminal end of cagII) is not necessary for translocation of cagA into the host cell or induction of interleukin IL8. It is associated with peptic ulcer and adenocarcinoma. Some of the study found connection of tnpA gene with peptic ulcer (9).
There are no published studies on the presence of H. pylori virulence genes in Croatia. Considering quite large number of patients with multiple unsuccessful eradication therapy, in spite of lack of clinical symptoms and benign endoscopic result, there is a question to pose whether to insist on eradication or not.
The aim of our study was to detect virulence genes of H. pylori just in these patients as a possible predictors of future severe gastroduodenal diseases, by comparing it with clinical and pathohistological results.
MATERIAL AND METHODS
Patients
The study analysed gastroscopic test results and bioptic specimens of gastric mucosa with positive H. pylori culture in 103 patients examined during routine, clinical gastroduodenoscopies in the endoscopic laboratory of the University Hospita Merkur in Zagreb during the period 2008.-2012. Microbiological and molecular analysis was performed at the Department for Clinical and Molecular Microbiology of the University Hospital Center in Zagreb and pathohistological testing of the gastric biopsy specimens at the Department for Pathology of University Hospital Merkur. The study was approved by the Ethical Comittee of the University Hospital Center Zagreb and University Hospital Merkur. The patients had signed the informed consent. Twenty-six men and seventy-seven woman in the age range of 28 to 80 years were included in the study. All patients were previously treated with eradication therapy for H. pylori. According to the endoscopic finding patients were classified in three groups: non ulcer dyspepsia (NUD), erosio/ulcus ventriculi (EUV), erosio/ulcus duodeni (EUD).
Bacterial culture
The biopsy specimens (one from corpus and one from antrum) were transported in tioglicolate broth, homogenized and seeded on Columbia agar with addition of 7% horse blood and Helicobacter pylori Selective Supplement SR 0147E (Oxoid) for cultivation of H. plyori. The plates were incubated in microaerophylic atmosphere with 100% humidity for 3-5 days. Identification was done based on macromorphology, micromorphology and biochemical testing (oxidase, urease, catalase). The strains were stored at -80°C in brucela broth with 10% glycerol.
DNA extraction
Extraction of chromosomal DNA was performed with commericial kit: High Pure PCR Template Preparation Kit, Version 16 (Roche Diagnostics Gmbh, Mannheim, Germany) according to the manufacturer's recommendation. The DNA was stored at -20ºC until used for molecular studies.
PCR amplification
PCR was used to detect the following genes: cagA1, cagA2, cagA3, cagE, cagM, cagT, cagA promotor region (Apcag), tnpA, tnpB and LEC using primers and conditions shown in Table 1 . (10-14) . A set of primers P1 and P2 that amplified a 26 kDa antigen (Ag) gene present in all strains of H. pylori was used as a positive PCR control. All PCR reactions were performed using a GeneAmpC PCR System 9700 (A6B Applied Biosystems. PCR products were visualised by electrophoresis in in 2% agarose gel, after staining with ethidium bromide and examined in UV transilluminator. A 100 bp DNA ladder (Sigma) was used as a size marker. Reference strains 47164 and 17874 (Culture collection, University of Goethenburg) were used a positive control.
Histology
Specimens for pathohistological analysis were fixed in a standard 4% neutral buffered formalin, and cut into slides. Slides were routinely stained ana analysed according to modified Sydney classification of gastritis (15). Metaplasiae were scored as yes or no, concerning that none of the patients had incomplete metaplasia of II or III grade. All metaplasias were of the I grade.
Statistical analysis
Age and complex scores were expressed as mean and standard deviation (SD). Comparison for complex scores were done using Student's t-test. Categorical variables were presented as frequencies (%). The comparison between subgroups for categorical variables were done using c test or Fischer exact test with the calculation of odds ration (OR) together with 95% confidence intervals (CI). Logistic regression analysis was used to calculate OR (95%CIs) for the association of the presence of individual genes with complex scores (OR was calculated for the 1-point change in complex score). A P value of <0.05 was considered statistically significant for all tests performed. The analysis was performed using STATISTICA, version 10. (StatSoft, Inc., OK, USA).
RESULTS
In the study were included 103 patients: 25 men and 78 woman in the age range of 28 to 81 years, with median age of 55.8 years (SD±11.8). According to endoscopic results patients were classified into three groups: 68 (66%) with non-ulcer dyspepsia (NUD), 22 (21.4%) with erosio/ulcus ventriculi (EUV), and 13 (12.6%) with erosio/ulcus duodeni (EUD).
Out of 103 H. pylori isolates 16 (15.5%) had deleated cagPAI, and 87 (84.5%) partially deleated cagPAI. None of the isolates had intact cagPAI. There was no statistically significant difference in the distribution of cagPAI either according to the gender (c2=0.005, df=1, p= 0.941) or according th the endoscopic diagnosis (c2=1.142 df=2, p= 0.565) as shown in Table 2 .
The frequency of particular genes was as follows: cagA1 71.8%, cagA2 69.9%, cagA3 5.8%, cagE 75.7%, cagM 71.8%, tnpA 9.7%, cagT 68%, Apcag 63.1%, LEC 48.5% and tnpB 7.8% as shown in Figure 1 . 
Virulence genes of Helicobacter pylori
Pathohistological analysis of antrum revealed inflammation in all patients (100%), activity was found in 66% of the patients, atrophy in 6.8% and intestinal metaplasia in 24.3%. All patients had inflammation in the corpus. Activity was found in 62.2% of the patients. Atrophy was present in 4.9% and metaplasia in 13.6% of the patients. Table 3 . shows the distribution of different grades of pathohistological parameters of gastritis in the antrum and corpus.
There was no statistically significant difference in pathohistological lesions between the patients with parcially deleated cagPAI and those with deleated cagPAI (p>0.05 for all parameters describing pathohistological lesions).
The presence of CagA2 was significantly related to the higher grade of inflammation of antrum (c2=6.872, df=2, p=0.032), with increased density of H. pylori in the corpus (c2=16.7, df=3, p=0.001), and with higher total score for the corpus (mean±SD=4.1±1.5 for CagA2+, 3.3±1.4 for CagA2, t=2.687, p=0.008) as shown in Table 4 .
The presence of Apcag was significantly correlated with higher inflammatory score of antrum (Apcag+:mean± SD=4.9±1.7; Apcag-: 4.0±1.7; t=2.332, p=0.022) ( Table 4 ).
The presence of cagM was related to the higher densitiy of H. pylori in the corpus (c2=9.864, df=3, p=0.020). and higher total score for the corpus (CagM+: mean±SD=4.1±1.6; CagM-: 3.4±1.4;t=2.021, p=0.046) ( Table 4 ).
The presence of cagT and LEC was related to less frequency of antrum atrophy (cagT, c2=5.35, df=1, p=0.021).
Correlation between any of ten cagPAI genes and endoscopic diagnosis (p>0.16 for all) was not found in this study.
DISCUSSION
In our study, we amplified 10 H. pylori genes in order to characterize cagPAI. Intact cagPAI was not found but there was 84.5% parcially deleated, and 15.5% completely EUV -erosio/ulcus ventriculi; EUD -erosio/ulcus duodeni; NUDnon-ulcer dyspepsia. deleated. In contrast, in the study done in Mexico which included 11 genes, there was 90% of intact cagPAI, 4% of parcially delated and 6% of completely deleated (16) .
We want to emphasise that there is disconcordance between different studies in the number of cagPAI genes analysed, and the definition of intact, deleated and parcially deleated cagPAI. Most studies analysed limited number of genes. Salih et al. analyzed 4 genes of cagPAI and reported 42.1% of intact, 39.5% of partially deleated and 18.4% completely deleated cagPAI and the correlation of intact cagPAI and duodenal ulcer (17) . Baghaei et al. analyzed three genes and reported 17% of intact cagPAI, 62% of partially deleated and 20% of completely deleated in Iran population (8). Nygen et al. analysed 30 genes with the same number of strains and similar endoscopic diagnosis as in our study and found 88% of intact, and 12% of parcially deleated in Vietnam population (18) . Based on bibliographical data it is evident that the frequency of intact cagPAI varies depending on the geographic area.
Results of our study did not demonstrate any correlation between deleated and partially deleated cagPAI and either endoscopic diagnosis or pathohistological lesions. It is hard to explain wheter our results reflect the situation in our geographic region or if they are related to a specific category of patients with predominant non-ulcer dyspepsia. The study from Maeda et al. from Japan confirmed our observation that partially deleated cagPAI is associated with non-ulcer dyspepsia in contrast with intact cagPAI found in patients with gastric cancer (19) . We do not have the data for different categories of patients with other grades of gastroduodenal disease. This is the first study of genotyping of cagPAI in Croatia. The future studies should be focused on genotyping of cagPAI in Croatian patients with severe gastroduodenal disease.
CagA is considered to be a marker of cagPAI region (20) . In our study we analysed three different segment of cagA gene. cagA1 segment close to the promoter region, middle segment cagA2 and right end cagA3. While the rate of cagA1 and cagA2 positivity was similar (71.8%) and (69.9%) respectively, the frequency of cagA3 was low (5.8%). The frequent deletion of cagA3 compared to cagA1 and cagA2 in the control strains reported by Matar et al. was attributed to decreases pathogenicity (9). Prevalence of cagA positive strains differs between the countries and is the highest in East Asia (90%), Japan (100%) (21) and Bulgaria (84.9%) (22) . The moderate prevalence was found in Iran (62%) (23), Slovenia (61%) (24) , Columbia (64%) (21), Turkey (49%) (25) , Equador (46%) (26) and Portugal (31.8%) (27) . The previous studies on H. pylori in Croatia reported the prevalence of serum antibodies However, some studies did not find any significant relationship between cagA positivity and H. pylori density, neutrophil activity, lymphoid aggregation in lamina propria and glandular atrophy in the biopsies, but significant association was detected with severe chronic gastritis (23) .
The frequency of cagE in our study was higher than of cagA (75.7% vs 71.8%). This is in agreement with some studies which consider cagE to be a better marker of cagI region than cagA (9, 36). We did not find any association between cagE and endoscopic diagnosis and pathohistological lesions which is in agreement with the results from a study conducted in Portugal where cagE is more prevalent than cagA (27) . Modena at al. have not found association between cagE and clinical outcome (37), contrarily to the studies which described higher frequency of cagE and sever gastroduodenal disease such as ulcer and gastric cancer, than in gastritis (3). CagT as a marker of cagII region was identified in 68% of our isolates and was associated with decreased frequency of antrum atrophy without any correlation with clinical diagnosis. However, some authors did not report correlation with either clinical diagnosis or pathohistological alterations of gastric mucosa (8). Mattar et al. reported that 98% of the patients with ulcer disease retained cagT gene (9), while the isolates with deleted cagT were more frequent in the patients with chronic gastritis compared with peptic ulcer disease or gastric cancer in Japanese population (12 This study comprised the patients without successfull eradication of H. pylori infection after multiple antibiotic courses in spite of the fact that antimicrobial therapy was after one or two unsuccessful therapeutic outcomes created in accordance with antimicrobial susceptibility testing.
The most patients had normal or harmless endoscopic result (non-ulcer dispepsia). Although pathological alterations did not point out to the danger of premalignant lesions our study found a high frequency of cagA, ApCag, cagT and cagM genes in the isolates recovered from the patients included in the study. The correlation between the presence of these genes and higher degree of serious pathohistological lesions in gastric mucosa was observed. According the the results of the present study it could be concluded that the presence of these genes can predispone for the development of ulcer, premalignant or malignant diseases. Thus, insisting on eradication of H. pylori in spite of harmless endoscopis and histological results should be considered as the only correct choice.
In spite of the fact that application of molecular diagnostics in detection of virulence genes is too expensive and not recommended for routine diagnostic, it should have a role in selected patients with unsuccessful eradication therapy with usual therapeutic protocols.
Moreover, the genomic profiles generated in this study may be useful for interlaboratory comparisons and are suitable for storage in epidemiological databases for comparative analyses. Our study has been focused on a specific group of patients isolates and may be representative for isolates from patients in this geographic region in Croatia. Future studies are needed to involve other disease specific strain group with appropriate controls.
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